About Pharmsol India Private Limited
Data last updated:
Pharmsol India Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Pharmsol Holding Limited. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 02 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74140TG2014PTC095488. Its GSTIN is 36AAHCP8042K1Z2 (Telangana).
The company has an authorised share capital of ₹85 Lakh and a paid-up capital of ₹8.08 Lakh. It is led by directors Srirengarajan Lakshminarasimhan and Sunil Kumar Shambhulal Doshi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.26 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.06 Lakh (net margin 0.9%) and EBITDA of ₹16.89 Lakh (EBITDA margin 7.5%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 2% over five years.
The company is associated with 1 brand: PharmSol.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharm-sol.com.
Company details
Contact details
Pharmsol India Private Limited's registered office is in Hyderabad, Telangana. Its website is pharm-sol.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH.No.1 – 90/C/1 Plot 3 Sy No. 84 Unit 406 4th Floor Gowra Fountainhead Hudatechnoenclave Pa, Trikanagar, Hyderabad, Telangana, India – 500081
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Pharmsol India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Pharmsol India operates one associated brand: PharmSol. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pharmaceutical products, technologies, audits, and regulatory solutions globally. | pharm-sol.com |
Business activity
The main business activity of Pharmsol India is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Pharmsol India Private Limited, buy the company report.
Financials of Pharmsol India Private Limited
FY 2024 filings availablePharmsol India Private Limited reported revenue of ₹2.26 Cr (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 10% fall in the latest year. EBITDA rose 496% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmsol India Private Limited, buy the company report.
Board of directors of Pharmsol India Private Limited
Pharmsol India has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srirengarajan Lakshminarasimhan | Director | 29 Jul 2022 | 4 Years 2 Months | Current |
| Sunil Kumar Shambhulal Doshi | Director | 22 Apr 2016 | 10 Years 6 Months | Current |
Peer comparison
Pharmsol India Private Limited is compared with the 3 companies closest to it by revenue in the Outsourcing industry (Consulting Services), with the same principal business activity (other support services to organizations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mavcomm Consulting Private Limited | ₹2.26 Cr (FY 2021) | 4.0% | New Delhi, Delhi, India | |||
| Pharmsol India Private Limitedthis company | ₹2.26 Cr (FY 2025) | ₹2.06 Lakh | 0.9% | -10.0% | Hyderabad, Telangana, India | |
| Shuka Consultancy Services Private Limited | ₹2.26 Cr (FY 2025) | -22.0% | Chennai, Tamil Nadu, India | |||
| Qurant Private Limited | ₹2.25 Cr (FY 2025) | 95.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Pharmsol India Private Limited, buy the company report.
Auditor
Pharmsol India Private Limited is audited by MURMURIA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MURMURIA & ASSOCIATES | FY 2024 | 052943 |
Shareholding
The shareholding of Pharmsol India Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharmsol India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pharmsol India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmsol India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pharmsol India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCP8042K1Z2 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pharmsol India Private Limited, buy the company report.
Recent activity
Pharmsol India Private Limited has 6 board changes on record since 2016: 2 appointments and 4 cessations. The latest: Ravikanth Mandapati ceased to be Director on 13 Sep 2023.
Frequently asked questions
Pharmsol India is an active private limited company based in Hyderabad, Telangana, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 02 September 2014 (12+ years old) and is registered under CIN U74140TG2014PTC095488.
Pharmsol India has 2 current directors:
- Srirengarajan Lakshminarasimhan - Director
- Sunil Kumar Shambhulal Doshi - Director
The latest financial statements of Pharmsol India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharmsol India is 36AAHCP8042K1Z2, registered in Telangana.
The CIN (Corporate Identification Number) of Pharmsol India is U74140TG2014PTC095488. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmsol India was incorporated on 02 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Pharmsol India by revenue are Mavcomm Consulting Private Limited, Shuka Consultancy Services Private Limited, Qurant Private Limited, all in the Outsourcing industry (Consulting Services), with the same principal business activity (other support services to organizations).
Ravikanth Mandapati ceased to be Director on 13 Sep 2023. Srirengarajan Lakshminarasimhan ceased to be Additional Director on 30 Sep 2022. Srirengarajan Lakshminarasimhan was appointed as Director on 29 Jul 2022. Pharmsol India has 6 board changes on record in total.
Pharmsol India can be reached through the website pharm-sol.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Pharmsol India is at H.No.1 – 90C1 Plot 3 Sy No. 84 Unit 406 4th Floor Gowra Fountainhead Hudatechnoenclave Pa, Trikanagar, Hyderabad, Telangana, India – 500081.
Pharmsol India operates in the business outsourcing industry, in the business and IT consulting segment.